# Locus Biosciences

CDMO服务 — 可扩展的GMP生产.

Source: https://cn.bioecon.ru/companies/locus-biosciences/
Updated: 2026-07-02

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 融资总额介于 $136.23M 至 $165.4M | https://prospeo.io/c/locus-biosciences-revenue |
| 产能 | 每年数百万剂，单个噬菌体生产规模最高达200升 | https://www.locus-bio.com/guardian/ |
| 认证 | 2021年ISPE Facility of the Year Award（荣誉提名） | https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| 监管批准 | 符合美国（FDA）和国际标准（EMA、PMDA） | https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| 生产基地 | 位于北卡罗来纳州莫里斯维尔（Morrisville）的12,000平方英尺cGMP设施 | https://bekbg.com/projects/locus-biosciences/, https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/guardian/, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| 员工人数 | 截至2026年为55-61名员工 [中等置信度] | https://prospeo.io/c/locus-biosciences-revenue |
| 营收 | 估计年收入介于 3M 至 15.9M 美元 [中等置信度] | https://prospeo.io/c/locus-biosciences-revenue |

独立来源: bekbg.com, ipsdb.com, locus-bio.com, prospeo.io

## 技术

- [噬菌体疗法](https://cn.bioecon.ru/technology/bacteriophage-therapy/)